Icon rejects Pfizer's Sandwich, but is hungry for 800 of its staff
This article was originally published in Scrip
Executive Summary
In a Q2 earnings call with analysts, Icon CEO Peter Gray made it clear that the CRO will not take on Pfizer's facility in Sandwich, UK, as part of the preferred partnership deal it signed with the pharmaceutical giant at the end of May, that will see the research sponsor cull its strategic alliances from 17 to two.